Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIDAC: Screening for Primary Immunodeficiency in Adults With Recurrent/Severe Bacterial Infections
NCT02972281Completed
- Sponsor
- CHU de Lille
- Start
- Mar 2015
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Lille. Primary endpoint: Frequency of Primary immunodeficiencies (PIDs) at 6 months. Started Mar 2015; status: completed.
Beyond the preview
Go deeper on NCT02972281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972281.